Sabaa International Company for Pharmaceutical and Chemical
Last Updated:
- 5.28 EGP
- -0.07
- -1.31%
سبأ الدولية للأدوية والصناعات الكيماوية
سبأ
Symbol :
SIPC
ISIN :
EGS382M1C011
52-Week Range :
2.62
-
7.28
Turnover Ratio :
7.54
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Sabaa International Company for Pharmaceutical and Chemical Announcements
Top News
- A 19-May Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
- B 07-April FRA approves Sabaa Pharmaceutical's capital raise
- C 21-March Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
- D 22-July Sabaa expected to produce 250K doses of Favipiravir in 6M
- E 13-July Sabaa Pharmaceutical obtains initial approval to register COVID-19 drug
- F 09-May Sabaa Pharmaceutical approves treasury stocks sale
- G 09-March Sabaa Pharmaceutical EGM to mull capital hike 1 April
- H 28-February Sabaa Pharmaceutical proposes 3m bonus shares
- I 19-February EGX suspends trading on 3 stocks
- J 07-November Sabaa International profits decline 4.8% in 9M
- K 13-October Three Egyptian listed companies finish off stock buyback
- L 26-September Sabaa Pharmaceutical completes expansions worth EGP22m
